|Last Price$160.60||Day Change (%)1.43%|
|Open Price$158.36||Day Change ($)2.26|
|Day Range157.47–161.60||52-Week Range142.38–215.73|
As of Fri 10/9/2015 7:30:00 PM | USD
Perrigo, Hain Celestial And Hutchison China MediTech Bring Earth's Best Organic® Infant Formula To $16.5 Billion China Formula Market
Perrigo asks shareholder to reject Mylan's latest bid
Perrigo Responds to Misleading Letter from Mylan Executive Chairman
Perrigo Animal Health, Walmart Provide Ultimate Protection for Atlanta Police Patrol K-9s
Mylan takes buyout offer for Perrigo directly to shareholders
The continuing U.S. stock market rally has diminished the number and similarity of purchases across these top managers.
Recent deals have been driven more by tax strategies than therapeutic synergies.
Favorable conditions are in place for merger-arbitrage ETFs, including increasing M&A activity and the likelihood of higher interest rates.